MELINDA VICKERS: Open Payments
NPI 1164019345 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 20 payments from 12 companies in 2025. Trend: 2023 $434 · 2024 $256 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $107 |
| E.R. Squibb & Sons, L.L.C. | 1 | $103 |
| JAZZ PHARMACEUTICALS INC. | 3 | $81 |
| Legend Biotech USA Inc. | 2 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Syndax Pharmaceuticals, Inc. | 1 | $33 |
| Kite Pharma, Inc. | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Janssen Scientific Affairs, LLC | 1 | $20 |
Products named: CARVYKTI, RYLAZE, TALVEY, Vanflyta, Yescarta, DEFITELIO, DARZALEX, LIVTENCITY.
Industry payments across AZ — which companies pay providers there.
